Skip to content
PubMed This is a summary of 91 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 91 referenced papers

Top Authors

Aditi Prashant Sinha
All India Institute of Medical Sciences
Arvind Bagga
All India Institute of Medical Sciences
Olivia Boyer
Hôpital Necker-Enfants Malades
Marina Vivarelli
Bambino Gesù Children's Hospital
Pankaj Hari
All India Institute of Medical Sciences
Moin Ahson Saleem
Bristol Royal Hospital for Children
Francesco Emma
Bambino Gesù Children's Hospital
Hee Gyung Kang
Seoul National University Children's Hospital
Fatih Özaltın
Hacettepe University
Franz S. Schaefer
Heidelberg University

Top Institutions

Ranked by publications Top 10 institutions
10

Bristol Royal Hospital for Children

Bristol, United Kingdom

24 papers

References

References (91)
  1. 1

    Levamisole in steroid-sensitive nephrotic syndrome: usefulness in adult patients and laboratory insights into mechanisms of action via direct action on the kidney podocyte.

    Jiang L, Dasgupta I, Hurcombe JA, et al.

    Clinical science (London, England : 1979) 2015; (128(12)):883-93 doi:10.1042/CS20140749.

    PMID: 25626449
  2. 2

    Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort.

    Trautmann A, Bodria M, Ozaltin F, et al.

    Clinical journal of the American Society of Nephrology : CJASN 2015; (10(4)):592-600 doi:10.2215/CJN.06260614.

    PMID: 25635037
  3. 3

    KANK deficiency leads to podocyte dysfunction and nephrotic syndrome.

    Gee HY, Zhang F, Ashraf S, et al.

    The Journal of clinical investigation 2015; (125(6)):2375-84.

    PMID: 25961457
  4. 4

    Variability in phenotype induced by the podocin variant R229Q plus a single pathogenic mutation.

    Phelan PJ, Hall G, Wigfall D, et al.

    Clinical kidney journal 2015; (8(5)):538-42 doi:10.1093/ckj/sfv063.

    PMID: 26413278
  5. 5

    Pathophysiology, Evaluation, and Management of Edema in Childhood Nephrotic Syndrome.

    Ellis D

    Frontiers in pediatrics 2015; (3()):111 doi:10.3389/fped.2015.00111.

    PMID: 26793696
  6. 6

    Pathology of Podocytopathies Causing Nephrotic Syndrome in Children.

    Ranganathan S

    Frontiers in pediatrics 2016; (4()):32 doi:10.3389/fped.2016.00032.

    PMID: 27066465
  7. 7

    Long-term Outcomes of Childhood Onset Nephrotic Syndrome.

    Hjorten R, Anwar Z, Reidy KJ

    Frontiers in pediatrics 2016; (4()):53 doi:10.3389/fped.2016.00053.

    PMID: 27252935
  8. 8

    Genotype-phenotype analysis of pediatric patients with WT1 glomerulopathy.

    Ahn YH, Park EJ, Kang HG, et al.

    Pediatric nephrology (Berlin, Germany) 2017; (32(1)):81-89 doi:10.1007/s00467-016-3395-4.

    PMID: 27300205
  9. 9

    FSGS: Diagnosis and Diagnostic Work-Up.

    Sprangers B, Meijers B, Appel G

    BioMed research international 2016; (2016()):4632768 doi:10.1155/2016/4632768.

    PMID: 27314022
  10. 10

    Steroid Resistant Nephrotic Syndrome-Genetic Consideration.

    Tasic V, Gucev Z, Polenakovic M

    Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki) 2015; (36(3)):5-12.

    PMID: 27442391
  11. 11

    The role of plasma exchange in treating post-transplant focal segmental glomerulosclerosis: A systematic review and meta-analysis of 77 case-reports and case-series.

    Kashgary A, Sontrop JM, Li L, et al.

    BMC nephrology 2016; (17(1)):104 doi:10.1186/s12882-016-0322-7.

    PMID: 27473582
  12. 12

    The relatively poor correlation between random and 24-hour urine protein excretion in patients with biopsy-proven glomerular diseases.

    Hogan MC, Reich HN, Nelson PJ, et al.

    Kidney international 2016; (90(5)):1080-1089 doi:10.1016/j.kint.2016.06.020.

    PMID: 27528553
  13. 13

    Interventions for idiopathic steroid-resistant nephrotic syndrome in children.

    Hodson EM, Wong SC, Willis NS, Craig JC

    The Cochrane database of systematic reviews 2016; (10()):CD003594 doi:10.1002/14651858.CD003594.pub5.

    PMID: 27726125
  14. 14

    Epidemiology of Acute Kidney Injury in Critically Ill Children and Young Adults.

    Kaddourah A, Basu RK, Bagshaw SM, et al.

    The New England journal of medicine 2017; (376(1)):11-20 doi:10.1056/NEJMoa1611391.

    PMID: 27959707
  15. 15

    Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis.

    Pérez V, López D, Boixadera E, et al.

    BMC nephrology 2017; (18(1)):49 doi:10.1186/s12882-017-0452-6.

    PMID: 28158993
  16. 16

    Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.

    Sinha A, Gupta A, Kalaivani M, et al.

    Kidney international 2017; (92(1)):248-257 doi:10.1016/j.kint.2017.01.019.

    PMID: 28318625
  17. 17

    Successful treatment with bortezomib and dexamethasone for proliferative glomerulonephritis with monoclonal IgG deposits in multiple myeloma: a case report.

    Noto R, Kamiura N, Ono Y, et al.

    BMC nephrology 2017; (18(1)):127 doi:10.1186/s12882-017-0524-7.

    PMID: 28385149
  18. 18

    Focal segmental glomerulosclerosis and medullary nephrocalcinosis in children with ADCK4 mutations.

    Park E, Kang HG, Choi YH, et al.

    Pediatric nephrology (Berlin, Germany) 2017; (32(9)):1547-1554 doi:10.1007/s00467-017-3657-9.

    PMID: 28405841
  19. 19

    Optimal management of primary focal segmental glomerulosclerosis in adults.

    Beaudreuil S, Lorenzo HK, Elias M, et al.

    International journal of nephrology and renovascular disease 2017; (10()):97-107 doi:10.2147/IJNRD.S126844.

    PMID: 28546764
  20. 20

    Long-Term Outcome of Steroid-Resistant Nephrotic Syndrome in Children.

    Trautmann A, Schnaidt S, Lipska-Ziętkiewicz BS, et al.

    Journal of the American Society of Nephrology : JASN 2017; (28(10)):3055-3065 doi:10.1681/ASN.2016101121.

    PMID: 28566477
  21. 21

    Neurotoxicity of cyclosporine A in children with steroid-resistant nephrotic syndrome: is cytotoxic edema really an unfavorable predictor of permanent neurological damage?

    Batinić D, Milošević D, Filipović-Grčić B, et al.

    Wiener klinische Wochenschrift 2017; (129(15-16)):579-582 doi:10.1007/s00508-017-1221-z.

    PMID: 28600697
  22. 22

    Nephrotic syndrome in infants and children: pathophysiology and management.

    Downie ML, Gallibois C, Parekh RS, Noone DG

    Paediatrics and international child health 2017; (37(4)):248-258 doi:10.1080/20469047.2017.1374003.

    PMID: 28914167
  23. 23

    Diagnosis and management of nephrotic syndrome.

    McCloskey O, Maxwell AP

    The Practitioner 2017; (261(1801)):11-5.

    PMID: 29020719
  24. 24

    Efficacy and safety of immunosuppressive medications for steroid-resistant nephrotic syndrome in children: a systematic review and network meta-analysis.

    Li S, Yang H, Guo P, et al.

    Oncotarget 2017; (8(42)):73050-73062 doi:10.18632/oncotarget.20377.

    PMID: 29069848
  25. 25

    Whole Exome Sequencing of Patients with Steroid-Resistant Nephrotic Syndrome.

    Warejko JK, Tan W, Daga A, et al.

    Clinical journal of the American Society of Nephrology : CJASN 2018; (13(1)):53-62 doi:10.2215/CJN.04120417.

    PMID: 29127259
  26. 26

    Genetic testing in steroid-resistant nephrotic syndrome: why, who, when and how?

    Preston R, Stuart HM, Lennon R

    Pediatric nephrology (Berlin, Germany) 2019; (34(2)):195-210 doi:10.1007/s00467-017-3838-6.

    PMID: 29181713
  27. 27

    Efficacy and Safety of Cyclosporine versus Tacrolimus in Steroid and Cyclophosphamide Resistant Nephrotic Syndrome: A Prospective Study.

    Prasad N, Manjunath R, Rangaswamy D, et al.

    Indian journal of nephrology 2018; (28(1)):46-52 doi:10.4103/ijn.IJN_240_16.

    PMID: 29515301
  28. 28

    Indications and results of renal biopsy in children: a 36-year experience.

    Santangelo L, Netti GS, Giordano P, et al.

    World journal of pediatrics : WJP 2018; (14(2)):127-133 doi:10.1007/s12519-018-0147-5.

    PMID: 29569185
  29. 29

    Acute kidney injury complicating nephrotic syndrome of minimal change disease.

    Meyrier A, Niaudet P

    Kidney international 2018; (94(5)):861-869 doi:10.1016/j.kint.2018.04.024.

    PMID: 29980292
  30. 30

    Nephrotic syndrome with acute pulmonary embolism in young adults: Two case reports.

    Song Z, Wu H, Cao H, et al.

    Medicine 2018; (97(29)):e11495 doi:10.1097/MD.0000000000011495.

    PMID: 30024529
  31. 31

    Management of steroid-resistant nephrotic syndrome in children and adolescents.

    Tullus K, Webb H, Bagga A

    The Lancet. Child & adolescent health 2018; (2(12)):880-890 doi:10.1016/S2352-4642(18)30283-9.

    PMID: 30342869
  32. 32

    Oliguria and Acute Kidney Injury in Critically Ill Children: Implications for Diagnosis and Outcomes.

    Kaddourah A, Basu RK, Goldstein SL, et al.

    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 2019; (20(4)):332-339 doi:10.1097/PCC.0000000000001866.

    PMID: 30676490
  33. 33

    Spontaneous bacterial peritonitis among adult patients with ascites attending Korle-Bu Teaching Hospital.

    Duah A, Nkrumah KN

    Ghana medical journal 2019; (53(1)):37-43 doi:10.4314/gmj.v53i1.6.

    PMID: 31138942
  34. 34

    Incidence and risk factors for major infections in hospitalized children with nephrotic syndrome.

    Kumar M, Ghunawat J, Saikia D, Manchanda V

    Jornal brasileiro de nefrologia 2019; (41(4)):526-533 doi:10.1590/2175-8239-JBN-2019-0001.

    PMID: 31528983
  35. 35

    Post-transplant recurrence of steroid resistant nephrotic syndrome in children: the Italian experience.

    Morello W, Puvinathan S, Puccio G, et al.

    Journal of nephrology 2020; (33(4)):849-857 doi:10.1007/s40620-019-00660-9.

    PMID: 31617157
  36. 36

    Molecular stratification of idiopathic nephrotic syndrome.

    Saleem MA

    Nature reviews. Nephrology 2019; (15(12)):750-765 doi:10.1038/s41581-019-0217-5.

    PMID: 31654044
  37. 37

    Correlation of urine protein/creatinine ratios to 24-h urinary protein for quantitating proteinuria in children.

    Huang Y, Yang X, Zhang Y, et al.

    Pediatric nephrology (Berlin, Germany) 2020; (35(3)):463-468 doi:10.1007/s00467-019-04405-5.

    PMID: 31813022
  38. 38

    Current understandings in treating children with steroid-resistant nephrotic syndrome.

    Lee JM, Kronbichler A, Shin JI, Oh J

    Pediatric nephrology (Berlin, Germany) 2021; (36(4)):747-761 doi:10.1007/s00467-020-04476-9.

    PMID: 32086590
  39. 39

    Genetic tests in children with steroid-resistant nephrotic syndrome.

    Cheong HI

    Kidney research and clinical practice 2020; (39(1)):7-16 doi:10.23876/j.krcp.20.001.

    PMID: 32155690
  40. 40

    Response to First Course of Intensified Immunosuppression in Genetically Stratified Steroid Resistant Nephrotic Syndrome.

    Mason AE, Sen ES, Bierzynska A, et al.

    Clinical journal of the American Society of Nephrology : CJASN 2020; (15(7)):983-994 doi:10.2215/CJN.13371019.

    PMID: 32317330
  41. 41

    IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome.

    Trautmann A, Vivarelli M, Samuel S, et al.

    Pediatric nephrology (Berlin, Germany) 2020; (35(8)):1529-1561 doi:10.1007/s00467-020-04519-1.

    PMID: 32382828
  42. 42

    Podocytopathies.

    Kopp JB, Anders HJ, Susztak K, et al.

    Nature reviews. Disease primers 2020; (6(1)):68 doi:10.1038/s41572-020-0196-7.

    PMID: 32792490
  43. 43

    Identification of disease-causing variants by comprehensive genetic testing with exome sequencing in adults with suspicion of hereditary FSGS.

    Braunisch MC, Riedhammer KM, Herr PM, et al.

    European journal of human genetics : EJHG 2021; (29(2)):262-270 doi:10.1038/s41431-020-00719-3.

    PMID: 32887937
  44. 44

    Consensus Guidelines on Management of Steroid-Resistant Nephrotic Syndrome.

    Vasudevan A, Thergaonkar R, Mantan M, et al.

    Indian pediatrics 2021; (58(7)):650-666.

    PMID: 33408286
  45. 45

    Pulmonary Embolism in Children: A Case Series.

    Agrawal S, Shrivastava Y, Bolia R, et al.

    Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine 2020; (24(12)):1272-1275 doi:10.5005/jp-journals-10071-23682.

    PMID: 33446985
  46. 46

    Seroprotection for Diphtheria, Pertussis, Tetanus and Measles in Children With Nephrotic Syndrome.

    Ajay M, Mantan M, Dabas A, et al.

    Indian pediatrics 2021; (58(3)):233-236.

    PMID: 33713058
  47. 47

    Next-Generation Sequencing for Congenital Nephrotic Syndrome: A Multi-Center Cross-Sectional Study from India.

    Joshi A, Sinha A, Sharma A, et al.

    Indian pediatrics 2021; (58(5)):445-451.

    PMID: 33980730
  48. 48

    A critical re-analysis of cases of post-transplantation recurrence in genetic nephrotic syndrome.

    Mason AE, Saleem MA, Bierzynska A

    Pediatric nephrology (Berlin, Germany) 2021; (36(11)):3757-3769 doi:10.1007/s00467-021-05134-4.

    PMID: 34031708
  49. 49

    UK experience of ofatumumab in recurrence of focal segmental glomerulosclerosis post-kidney transplant.

    Reynolds BC, Lamb A, Jones CA, et al.

    Pediatric nephrology (Berlin, Germany) 2022; (37(1)):199-207 doi:10.1007/s00467-021-05248-9.

    PMID: 34383125
  50. 50

    Liposorber® LA-15 system for LDL apheresis in resistant nephrotic syndrome patients.

    Al-Mousily M, Nicoara O, Selewski DT, Twombley K

    Pediatric nephrology (Berlin, Germany) 2022; (37(3)):585-592 doi:10.1007/s00467-021-05211-8.

    PMID: 34453196
  51. 51

    Therapeutic Response and Long-Term Renal Outcomes in Childhood Idiopathic Steroid-Resistant Nephrotic Syndrome: A Single-Center Study.

    Jung J, Lee JH, Park YS

    Nephron 2022; (146(4)):327-334 doi:10.1159/000520362.

    PMID: 34929692
  52. 52

    Risk of Arterial Thromboembolism, Venous Thromboembolism, and Bleeding in Patients with Nephrotic Syndrome: A Population-Based Cohort Study.

    Vestergaard SV, Birn H, Darvalics B, et al.

    The American journal of medicine 2022; (135(5)):615-625.e9 doi:10.1016/j.amjmed.2021.11.018.

    PMID: 34979093
  53. 53

    Rituximab Use for the Treatment of Childhood Nephrotic Syndrome by Canadian Pediatric Nephrologists: A National Survey.

    Meeuwisse C, Morgan CJ, Samuel S, et al.

    Canadian journal of kidney health and disease 2022; (9()):20543581221079959 doi:10.1177/20543581221079959.

    PMID: 35300066
  54. 54

    Pathological and Evolutive Correlations in Steroid Resistant Nephrotic Syndrome in Children.

    Starcea IM, Bogos RA, Scurtu G, et al.

    International journal of general medicine 2022; (15()):4187-4193 doi:10.2147/IJGM.S348346.

    PMID: 35469261
  55. 55

    Variation of the clinical spectrum and genotype-phenotype associations in Coenzyme Q10 deficiency associated glomerulopathy.

    Drovandi S, Lipska-Ziętkiewicz BS, Ozaltin F, et al.

    Kidney international 2022; (102(3)):592-603 doi:10.1016/j.kint.2022.02.040.

    PMID: 35483523
  56. 56

    A critical role of the podocyte cytoskeleton in the pathogenesis of glomerular proteinuria and autoimmune podocytopathies.

    Ye Q, Lan B, Liu H, et al.

    Acta physiologica (Oxford, England) 2022; (235(4)):e13850 doi:10.1111/apha.13850.

    PMID: 35716094
  57. 57

    Perceived family impact and coping mechanisms of caregivers of children with nephrotic syndrome.

    Cocorpus J, Jun J, Basalely A, et al.

    Pediatric nephrology (Berlin, Germany) 2023; (38(4)):1177-1185 doi:10.1007/s00467-022-05619-w.

    PMID: 35913565
  58. 58

    Childhood Steroid-resistant Nephrotic Syndrome: Long-term Outcomes from a Tertiary Care Center.

    Agrwal S, Mantan M, Dabas A, Batra VV

    Indian journal of nephrology 2022; (32(4)):320-326 doi:10.4103/ijn.ijn_258_21.

    PMID: 35967537
  59. 59

    Whole-exome sequencing of a multicenter cohort identifies genetic changes associated with clinical phenotypes in pediatric nephrotic syndrome.

    Jiao J, Wang L, Ni F, et al.

    Genes & diseases 2022; (9(6)):1662-1673 doi:10.1016/j.gendis.2022.03.023.

    PMID: 36157477
  60. 60

    Streptococcus pneumoniae meningitis in a child with idiopathic nephrotic syndrome: a case report.

    Guernsey D, Arun A, Agha R, Kupferman JC

    Journal of medical case reports 2022; (16(1)):403 doi:10.1186/s13256-022-03648-5.

    PMID: 36336675
  61. 61

    Multiple Venous and Pulmonary Artery Thrombosis as the Presenting Features of Spontaneously Reversible Nephrotic Syndrome after Exposure to SARS-CoV-2 Virus (Pfizer/BioNTech BNT162b2) Vaccination.

    Thammathiwat T, Banjongjit A, Chumnumsiriwath P, et al.

    Vaccines 2022; (10(11)) doi:10.3390/vaccines10111888.

    PMID: 36366397
  62. 62

    A Systematic Review and Meta-Analysis of the Rate and Risk Factors for Post-transplant Disease Recurrence in Children With Steroid Resistant Nephrotic Syndrome.

    Morello W, Proverbio E, Puccio G, Montini G

    Kidney international reports 2023; (8(2)):254-264 doi:10.1016/j.ekir.2022.10.030.

    PMID: 36815113
  63. 63

    Key pathological features characterize minimal change disease-like IgA nephropathy.

    Wang TY, Chang FP, Yang AH, et al.

    PloS one 2023; (18(7)):e0288384 doi:10.1371/journal.pone.0288384.

    PMID: 37471324
  64. 64

    Childhood nephrotic syndrome.

    Vivarelli M, Gibson K, Sinha A, Boyer O

    Lancet (London, England) 2023; (402(10404)):809-824 doi:10.1016/S0140-6736(23)01051-6.

    PMID: 37659779
  65. 65

    Cerebral sinovenous thrombosis in children with nephrotic syndrome: systematic review and one new case.

    Konopásek P, Piteková B, Krejčová V, Zieg J

    Frontiers in pediatrics 2023; (11()):1207871 doi:10.3389/fped.2023.1207871.

    PMID: 37691772
  66. 66

    Diagnostic value of serum CRP, PCT and IL-6 in children with nephrotic syndrome complicated by infection: a single center retrospective study.

    Jia W, Dou W, Zeng H, et al.

    Pediatric research 2024; (95(3)):722-728 doi:10.1038/s41390-023-02830-9.

    PMID: 37773440
  67. 67

    Current approaches to overcome recurrent focal segmental glomerulosclerosis after kidney transplantation.

    Ahmad SB, Peleg Y, Ahn W

    Current opinion in nephrology and hypertension 2024; (33(1)):61-66 doi:10.1097/MNH.0000000000000946.

    PMID: 37921337
  68. 68

    Intravenous cyclophosphamide therapy in children with calcineurin inhibitor-resistant steroid-resistant nephrotic syndrome in a resource-limited setting.

    Saiteja P, Deepthi B, Krishnasamy S, et al.

    Pediatric nephrology (Berlin, Germany) 2024; (39(4)):1149-1160 doi:10.1007/s00467-023-06187-3.

    PMID: 37947902
  69. 69

    Drug-induced glomerular diseases.

    Garnier AS, Laubacher H, Briet M

    Therapie 2024; (79(2)):271-281 doi:10.1016/j.therap.2023.10.010.

    PMID: 37973491
  70. 70

    Efficacy of combined rituximab and daratumumab treatment in posttransplant recurrent focal segmental glomerulosclerosis.

    Angeletti A, Bin S, Magnasco A, et al.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2024; (24(4)):688-692 doi:10.1016/j.ajt.2023.12.010.

    PMID: 38101474
  71. 71

    Cyclophosphamide Toxicity in Pediatric Nephrotic Syndrome Patient: A Case Report and Literature Review.

    Patil S, Patil MV, Bagalkotkar A, Wali S

    Current drug safety 2024; (19(4)):489-496 doi:10.2174/0115748863281214231213075642.

    PMID: 38204270
  72. 72

    Nephrotic Syndrome in a Child With NPHS2 Mutation.

    Tollaksen R, Craver RD, Yosypiv IV

    Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 2024; (27(4)):359-363 doi:10.1177/10935266231223274.

    PMID: 38291869
  73. 73

    Risk factors and renal outcomes of AKI in children with secondary steroid-resistant nephrotic syndrome.

    Yu N, Ouyang X, Li J, et al.

    Renal failure 2024; (46(1)):2314637 doi:10.1080/0886022X.2024.2314637.

    PMID: 38383285
  74. 74

    Comparison of different genetic testing modalities applied in paediatric patients with steroid-resistant nephrotic syndrome.

    Cheng X, Chen J, Yang X, et al.

    Italian journal of pediatrics 2024; (50(1)):85 doi:10.1186/s13052-024-01655-4.

    PMID: 38654395
  75. 75

    A Review of Focal Segmental Glomerulosclerosis Classification With a Focus on Genetic Associations.

    Bonilla M, Efe O, Selvaskandan H, et al.

    Kidney medicine 2024; (6(6)):100826 doi:10.1016/j.xkme.2024.100826.

    PMID: 38765809
  76. 76

    Autoantibodies Targeting Nephrin in Podocytopathies.

    Hengel FE, Dehde S, Lassé M, et al.

    The New England journal of medicine 2024; (391(5)):422-433 doi:10.1056/NEJMoa2314471.

    PMID: 38804512
  77. 77

    IPNA consensus definitions for clinical trial outcomes in steroid-resistant nephrotic syndrome.

    Hari P, Khandelwal P, Boyer O, et al.

    Pediatric nephrology (Berlin, Germany) 2025; (40(3)):865-872 doi:10.1007/s00467-024-06543-x.

    PMID: 39384644
  78. 78

    An international, multi-center study evaluated rituximab therapy in childhood steroid-resistant nephrotic syndrome.

    Chan EY, Sinha A, Yu ELM, et al.

    Kidney international 2024; (106(6)):1146-1157 doi:10.1016/j.kint.2024.09.011.

    PMID: 39395629
  79. 79

    Management and long-term outcome of recurrent idiopathic FSGS in pediatric kidney transplant recipients.

    Plonsky-Toder M, Pollack S, Tibi R, et al.

    Scientific reports 2024; (14(1)):25493 doi:10.1038/s41598-024-74184-z.

    PMID: 39461970
  80. 80

    Incidence and Risk Factors for Hypertension among Children with Nephrotic Syndrome.

    Robinson C, Wagner S, Aman N, et al.

    The Journal of pediatrics 2025; (284()):114443 doi:10.1016/j.jpeds.2024.114443.

    PMID: 39710174
  81. 81

    Outcomes and prognostic factors in childhood-onset steroid-resistant nephrotic syndrome: a retrospective single-center study.

    Zerkowitz E, Gellermann J, Beckus J, et al.

    Pediatric nephrology (Berlin, Germany) 2025; (40(7)):2239-2252 doi:10.1007/s00467-025-06705-5.

    PMID: 40021511
  82. 82

    Interventions for idiopathic steroid-resistant nephrotic syndrome in children.

    Liu ID, Willis NS, Craig JC, Hodson EM

    The Cochrane database of systematic reviews 2025; (5()):CD003594 doi:10.1002/14651858.CD003594.pub7.

    PMID: 40337980
  83. 83

    Whole genome sequencing identifies monogenic disease in 56.1% of families with early-onset steroid-resistant nephrotic syndrome.

    Soliman NA, Elmonem MA, El-Sayed AF, et al.

    Human genetics 2025; (144(7)):727-740 doi:10.1007/s00439-025-02752-y.

    PMID: 40402239
  84. 84

    Success of Coenzyme Q10 in Treating Steroid-Resistant Nephrotic Syndrome in Jordan: A Case Series.

    Frehat MQ, Alhadidi A, Almhairat A, et al.

    Cureus 2025; (17(4)):e83231 doi:10.7759/cureus.83231.

    PMID: 40453250
  85. 85

    Structural and functional insights of the podocyte slit diaphragm complex.

    Qadri AH, Prajapati J, Praghna D, et al.

    Tissue barriers 2026; (14(2)):2575198 doi:10.1080/21688370.2025.2575198.

    PMID: 41100809
  86. 86

    Lupus podocytopathy as a first renal manifestation in long-standing systemic lupus erythematosus: a case report.

    Togashi T, Fujisawa Y, Yano Y, et al.

    Modern rheumatology case reports 2025; (9(2)) doi:10.1093/mrcr/rxaf072.

    PMID: 41217175
  87. 87

    Managing concurrent nephrotic syndrome, spontaneous bacterial peritonitis, and herpes zoster in an immunocompromised child: Diagnostic difficulties and treatment outcomes.

    Adrizain R, Modjaningrat I, Winyarti , et al.

    IDCases 2026; (43()):e02489 doi:10.1016/j.idcr.2026.e02489.

    PMID: 41551359
  88. 88

    KDOQI US Commentary on the KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children.

    Wang CS, Gbadegesin R

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2026; (87(2)):141-152 doi:10.1053/j.ajkd.2025.10.006.

    PMID: 41577383
  89. 89

    Nephrotic Syndrome: Current Management.

    Vasudevan A, V H

    Indian journal of pediatrics 2026; (93(5)):507-514 doi:10.1007/s12098-026-06132-w.

    PMID: 41910850
  90. 90

    Monogenic variants drive low recurrence risk in pediatric steroid-resistant nephrotic syndrome after kidney transplantation: a high-consanguinity cohort.

    ALQattan F, Azzam A, Alkanani H, et al.

    Pediatric nephrology (Berlin, Germany) 2026; (41(11)):4127-4139 doi:10.1007/s00467-026-07430-3.

    PMID: 42350677
  91. 91

    Cutaneous Staphylococcus aureus Infections in Renal Edema Across Kidney Disease and the Intensive Care Unit: Pathophysiological Mechanisms, Clinical Implications, and Therapeutic Challenges.

    Caragea ME, Caragea DC, Novac MB, et al.

    International journal of molecular sciences 2026; (27(13)) doi:10.3390/ijms27136038.

    PMID: 42450304